The biotechnology company posted revenue of $1.4 million in the period. In the final minutes of trading on Monday, the company's shares hit 50 cents. A ...
News
- Advaxis: Fiscal Q2 Earnings Snapshot
- Novavax: Large study finds COVID-19 shot about 90% effective
The two-shot vaccine was about 90% effective overall, and preliminary data showed it was safe, the American biotechnology company said.
- Most popular places to live for alumni of 25 colleges
#4 place: San Antonio, Texas Area (2,531 alumni, 1.3% of graduates) ... computer sciences, and biomedical sciences, perfectly align with H-town's ...
- Novavax says its COVID vaccine is 90% effective in late-stage trial
Maryland-based biotech company Novavax said that its COVID-19 vaccine is 90.4% effective in a late-stage trial of nearly 30,000 people in the U.S. ...
- With surge in virus, Oman faces shortage of hospital beds
With health authorities now administering the Pfizer-Biotech vaccine in Oman, the government loosened a range of virus restrictions earlier this month, ...